PRACTICA No. 9
"Nephrology" (Madrid)
On-line version ISSN 1989-2284 printed version ISSN 0211-6995
Nefrología (Madr.) Vol.34 no.4 Cantabria 2014
http://dx.doi.org/10.3265/Nefrologia.pre2014.Apr.12349
LETTERS TO THE EDITOR
Infection with hepatitis C virus, interferon α and lupus, a curious association
Hepatitis C virus infection, interferon α and lupus; a curious combination
Correspondence address
Headmaster:
Drug-induced lupus is a syndrome that shares clinical and analytical characteristics with idiopathic systemic lupus erythematosus and appears after exposure to certain drugs that induce the formation of autoantibodies.
In 1945, Hoffman described the first case of drug-induced lupus, which involved the antibiotic sulfadiazine as the agent responsible for the condition. Eight years later, in 1953, Morrow et al. published a new case regarding the use of hydralazine1. Since then, the list of related drugs has been increasing and classic agents, such as procainamide, the aforementioned hydralazine, isoniazid or minocycline, have been joined in recent years by biological therapies such as tumor necrosis factor (TNF) and interferons (IFN) (table 1) 2,3,4
REFERENCE:Auñón-Rubio, P., Hernández-Martínez, E., Sevillano-Prieto, Á., & Morales-Ruiz, E. (2014). Infección por virus de la hepatitis C, interferón α y lupus, una curiosa asociación. Nefrología (Madrid), 34(4), 534-536.
